Digestive System Drugs Market
Global Digestive System Drugs Market Size, Share & Trends Analysis Report by Drug Type (Antacids, Laxatives, Antidiarrheal, and Antiemetics), by Dosage Form (Oral and Parenteral), and by Application (Irritable Bowel Syndrome, Crohn’s Disease, Gastroenteritis, and Others) Forecast 2022-2028
The global digestive system drugs market is anticipated to grow at a significant CAGR of 4.9% during the forecast period. The market for digestive system medications will be stifled by the expiration of patents on branded digestive system drugs. Pharmaceutical businesses, on the whole, spend a lot of money on medication development and patents. During the patent's validity period, the firm that owns the patent has exclusive rights to manufacture and distribute medications. After the patent expires, generic versions of the pharmaceuticals are produced by other companies at significantly lower prices than the original branded drugs. Overall, this will have a negative impact on the market's value growth. For instance, in November 2018, Ardelyx's Tenapanor medication has been approved by the FDA and the New Drug Application (NDA). This medication is a sodium transporter called NHE3 that aids in the treatment of constipation.
Impact of COVID-19 Pandemic on Global Digestive System Drugs Market
The COVID 19 has impacted a wide range of people. The majority of patients who have been infected with the COVID -19 have gastrointestinal problems. Manufacturers have made significant investments in the development of gastrointestinal treatments in response to the rising number of cases of stomach disorders. As a result, the global market for gastrointestinal drugs is growing. COVID 19 has a beneficial impact on the global market share of gastrointestinal medicines.
Segmental Outlook
The global digestive system drugs market is segmented based on the drug type, dosage type, and application. Based on the drug type, the market is segmented into antacids, laxatives, antidiarrheal, and antiemetics. Based on the dosage form, the market is sub-segmented into the oral and parenteral. Based on application the market is sub-segmented into irritable bowel syndrome, crohn’s disease, gastroenteritis, and others. Among these, the oral dosage form segment is anticipated to propel the growth of the market over the forecast period, owing to the change in the lifestyle of the people in which change in the eating habits, more inclination towards junk food and unhealthy lifestyle will further penetrate oral dosage form compared to the parenteral dosage form.
Global Digestive System Drugs Market Share by Application, 2021 (%)
The Irritable Bowel Segment is Anticipated to Hold a Prominent Share in the Global Digestive System Drugs Market
The cheap availability of medications to treat irritable bowel is one of the reasons for the segment's rapid rise. Due to the strong clinical urgency to combat the growing prevalence of irritable bowel, the category is expected to increase at a significant rate. This high frequency is related to a poor prognosis and bad food consumption, which might lead to a high risk of disease recurrence. For instance, In June 2019, Knight Therapeutics Inc. has submitted an oral sodium transporter NHE3 inhibitor with NDS. It aids in the treatment of irritable bowel syndrome in Canadians.
Regional Outlooks
The global digestive system drugs market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). Due to rising healthcare costs and an increase in digestive diseases, the North America region is seeing a boom. Another driving force in this region is the presence of a well-established healthcare sector.
Global Digestive System Drugs Market Growth, by Region 2022-2028
The Asia-Pacific Region is estimated to Hold the Major Share in the Global Digestive System Drugs Market
Due to the existence of densely populated countries such as China and India, the Asia-Pacific region has a high population density. The Asia-Pacific region's growth is fueled by an expanding number of patients, a growing geriatric population, and increased government investments in healthcare facilities. Another driving force in this region is the growing need for the most efficient and effective treatments. For instance, in March 2020 Sebela Pharmaceuticals received FDA approval for Pizensy (lactitol) from the United States Food and Drug Administration (FDA). This medication will aid in the treatment of (CIC) chronic idiopathic constipation, which is common in adults.
Market Players Outlook
The major companies serving the global digestive system drugs market include Abbott Laboratories Pvt. Ltd., AstraZeneca Plc., Cipla Inc., Takeda Pharmaceuticals Co. Ltd., Valeant Pharmaceuticals Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, In March 2021, Janssen Research and Development, LLC has begun a phase III clinical trial to assess ustekinumab's safety. This experiment will aid in the treatment of Crohn's disease in children with symptoms ranging from mild to severe.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global digestive system drugs market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Impact of COVID-19 on The Global Digestive System Drugs Market
- Recovery Scenario of Global Digestive System Drugs Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Abbott Laboratories Pvt. Ltd.
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. AstraZeneca Plc.
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Cipla Inc.
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Takeda Pharmaceuticals Co. Ltd.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Valeant Pharmaceuticals Inc.
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Digestive System Drugs Market by Drug Type
4.1.1. Antacids
4.1.2. Laxatives
4.1.3. Antidiarrheal
4.1.4. Antiemetics
4.2. Global Digestive System Drugs Market by Dosage Form
4.2.1. Oral
4.2.2. Parenteral
4.3. Global Digestive System Drugs Market by Application
4.3.1. Irritable Bowel Syndrome
4.3.2. Crohn’s Disease
4.3.3. Gastroenteritis
4.3.4. Others (Ulcerative Colitis, Celiac Disease)
5. Regional Analysis
5.1. North America
5.1.1. US
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. AbbVie Inc.
6.2. Allergan Plc.
6.3. Bausch Health Co. Inc.
6.4. Bayer AG
6.5. Boehringer Ingelheim Gmbh
6.6. Celltrion Healthcare Co. Ltd.
6.7. GlaxoSmithKline Plc.
6.8. Janssen Biotech Inc.
6.9. Johnson and Johnson Inc.
6.10. Lexicon Pharmaceuticals, Inc.
6.11. SANOFI
1. GLOBAL DIGESTIVE SYSTEM DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2021-2028 ($ MILLION)
2. GLOBAL ANTACIDS DIGESTIVE SYSTEM DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL LAXATIVES DIGESTIVE SYSTEM DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL ANTIDIARRHEAL DIGESTIVE SYSTEM DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL ANTIEMETICS DIGESTIVE SYSTEM DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL DIGESTIVE SYSTEM DRUGS MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2021-2028 ($ MILLION)
7. GLOBAL ORAL DIGESTIVE SYSTEM DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL PARENTERAL DIGESTIVE SYSTEM DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL DIGESTIVE SYSTEM DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
10. GLOBAL DIGESTIVE SYSTEM DRUGS BY IRRITABLE BOWEL SYNDROME MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL DIGESTIVE SYSTEM DRUGS BY CROHN’S DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL DIGESTIVE SYSTEM DRUGS BY GASTROENTERITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13. GLOBAL DIGESTIVE SYSTEM DRUGS BY OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
14. GLOBAL DIGESTIVE SYSTEM DRUGS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
15. NORTH AMERICAN DIGESTIVE SYSTEM DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
16. NORTH AMERICAN DIGESTIVE SYSTEM DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2021-2028 ($ MILLION)
17. NORTH AMERICAN DIGESTIVE SYSTEM DRUGS MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2021-2028 ($ MILLION)
18. NORTH AMERICAN DIGESTIVE SYSTEM DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
19. EUROPEAN DIGESTIVE SYSTEM DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
20. EUROPEAN DIGESTIVE SYSTEM DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2021-2028 ($ MILLION)
21. EUROPEAN DIGESTIVE SYSTEM DRUGS MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2021-2028 ($ MILLION)
22. EUROPEAN DIGESTIVE SYSTEM DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
23. ASIA-PACIFIC DIGESTIVE SYSTEM DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
24. ASIA-PACIFIC DIGESTIVE SYSTEM DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2021-2028 ($ MILLION)
25. ASIA-PACIFIC DIGESTIVE SYSTEM DRUGS MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2021-2028 ($ MILLION)
26. ASIA-PACIFIC DIGESTIVE SYSTEM DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
27. REST OF THE WORLD DIGESTIVE SYSTEM DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
28. REST OF THE WORLD DIGESTIVE SYSTEM DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2021-2028 ($ MILLION)
29. REST OF THE WORLD DIGESTIVE SYSTEM DRUGS MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2021-2028 ($ MILLION)
30. REST OF THE WORLD DIGESTIVE SYSTEM DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL DIGESTIVE SYSTEM DRUGS MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL DIGESTIVE SYSTEM DRUGS MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL DIGESTIVE SYSTEM DRUGS MARKET, 2021-2028 (%)
4. GLOBAL DIGESTIVE SYSTEM DRUGS MARKET SHARE BY DRUG TYPE, 2021 VS 2028 (%)
5. GLOBAL ANTACIDS DIGESTIVE SYSTEM DRUGS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL LAXATIVES DIGESTIVE SYSTEM DRUGS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL ANTIDIARRHEAL DIGESTIVE SYSTEM DRUGS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL ANTIEMETICS DIGESTIVE SYSTEM DRUGS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL DIGESTIVE SYSTEM DRUGS MARKET SHARE BY DOSAGE FORM, 2021 VS 2028 (%)
10. GLOBAL ORAL DIGESTIVE SYSTEM DRUGS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL PARENTERAL DIGESTIVE SYSTEM DRUGS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL DIGESTIVE SYSTEM DRUGS MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
13. GLOBAL DIGESTIVE SYSTEM DRUGS BY IRRITABLE BOWEL SYNDROME MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. GLOBAL DIGESTIVE SYSTEM DRUGS BY CROHN’S DISEASE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. GLOBAL DIGESTIVE SYSTEM DRUGS BY GASTROENTERITIS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16. GLOBAL DIGESTIVE SYSTEM DRUGS BY OTHERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
17. GLOBAL DIGESTIVE SYSTEM DRUGS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
18. US DIGESTIVE SYSTEM DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
19. CANADA DIGESTIVE SYSTEM DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
20. UK DIGESTIVE SYSTEM DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
21. FRANCE DIGESTIVE SYSTEM DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
22. GERMANY DIGESTIVE SYSTEM DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
23. ITALY DIGESTIVE SYSTEM DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
24. SPAIN DIGESTIVE SYSTEM DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
25. REST OF EUROPE DIGESTIVE SYSTEM DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
26. INDIA DIGESTIVE SYSTEM DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
27. CHINA DIGESTIVE SYSTEM DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
28. JAPAN DIGESTIVE SYSTEM DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
29. SOUTH KOREA DIGESTIVE SYSTEM DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
30. REST OF ASIA-PACIFIC DIGESTIVE SYSTEM DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
31. REST OF THE WORLD DIGESTIVE SYSTEM DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
